Severe Hypercapnia After Low-Flow Oxygen Therapy in Patients With Neuromuscular Disease and Diaphragmatic Dysfunction
Section snippets
PATIENTS AND METHODS
On review of the individual medical records of 118 consecutive adult patients, encountered during a 5-year period, who underwent phrenic nerve conduction studies and had a diagnosis of neuromuscular disease, we found 8 in whom results of the phrenic nerve conduction studies were abnormal and in whom repeated arterial blood gases (ABGs) were determined with the patient in the awake state before and after supplemental oxygen therapy. For these eight patients, demographic information, disease
RESULTS
A summary of the clinical and respiratory data for the study patients is shown in Table 1. The ABG responses before and after administration of supplemental oxygen and the time at which the tests were done are itemized in Table 2. The results of the phrenic nerve stimulation and diaphragmatic EMG response, the type of treatment, and the outcome of the study patients are summarized in Table 3. The mean age of the patients was 57 years, and the mean FVC, MVV, and Pimax were considerably decreased
DISCUSSION
Although this patient population had a variety of neuromuscular disorders, all patients had decreased or absent diaphragmatic EMG responses and moderate to severe reductions in the FVC. When admitted with the chief complaint of dyspnea, all patients were given low-flow oxygen therapy, and seven of the eight patients exhibited moderate to severe hypoxia and hypercapnia on initial ABG studies. Follow-up ABGs were determined primarily after changes in mental status and in three cases led to
CONCLUSION
Regardless of the underlying mechanisms for hypoventilation, data from the current study support the concept that, in patients with neuromuscular disease who have demonstrated diaphragmatic dysfunction and hypercapnia, supplemental oxygen therapy should be very closely monitored. Physicians should ideally repeat ABG studies after 60 minutes or less of supplemental oxygen therapy and be alert to the possibility of a substantial increase in the Paco2, level, especially if patients have
REFERENCES (20)
- et al.
The effects of alteration in pulmonary function and sleep parameters on survival in patients with amyotrophic lateral sclerosis
Mayo Clin Proc
(1991) - et al.
Electro-physiologic evaluation of phrenic nerves in severe respiratory insufficiency requiring mechanical ventilation
Chest
(1985) - et al.
Noninvasive ventilatory support during sleep improves respiratory failure in kyphoscoliosis
Chest
(1988) - et al.
Blunted respiratory drive in congenital myopathy
Am J Med
(1977) - et al.
Long-term follow-up of nocturnal ventilatory assistance in patients with respiratory failure due to Duchenne-type muscular dystrophy
Chest
(1990) - et al.
Nocturnal nasal ventilation for treatment of patients with hypercapnic respiratory failure
Mayo Clin Proc
(1991) - et al.
Determinants of hypoventilation during wakefulness and sleep in diaphragmatic paralysis
Am Rev Respir Dis
(1980) - et al.
Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease
Am Rev Respir Dis
(1987) - et al.
Effect of carbon dioxide on diaphragmatic function in human beings
N Engl J Med
(1984) - et al.
Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies
Thorax
(1983)
Cited by (93)
Management of acute respiratory failure in neuromuscular disease
2023, Pulmonary Assessment and Management of Patients with Pediatric Neuromuscular DiseaseMotor neuron, peripheral nerve, and neuromuscular junction disorders
2022, Handbook of Clinical NeurologyRespiratory Complications in Neuromuscular Disorders
2021, Neuromuscular Disorders: Treatment and ManagementQuantitation of oxygen-induced hypercapnia in respiratory pump failure
2016, Revista Portuguesa de Pneumologia (English Edition)Citation Excerpt :Intubation was averted by discontinuing the O2, and use of CNVS quickly normalized her CO2 level to 36 mm Hg. Consistent with the report of Gay and Edmonds,8 who found a mean increase in CO2 of 28.2 ± 23.3 mm Hg with O2 therapy for eight patients with NMD, the CO2 of our cases increased from 43.8 to 95.9 mm Hg or 52.1 ± 42.0 mm Hg (range of 21–59 to 56–177) over a mean 17.4 h (range of 20 min to 6 weeks). Whereas Gay and Edmonds did not use NVS or MIE, our cases 2, 3, 7, and 9 avoided intubation because of it.
207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: Management and implications for research, 27-29 June 2014, Naarden, The Netherlands
2015, Neuromuscular DisordersCitation Excerpt :Oxygen should not be used in acute respiratory muscle failure if not in addition to ventilator support. Oxygen alone has a higher risk to reduce bulbar respiratory drive and increase CO2 levels worsening the respiratory insufficiency itself [64]. Dr Philips and Ms Bowler from the Myotonic Dystrophy Support Group presented the Emergency Care Card which is being used in the UK.
Balancing the risks and benefits of oxygen therapy in critically ill adults
2013, ChestCitation Excerpt :Although many centers use higher oxygen saturation targets in appropriately monitored settings, judicious use of oxygen to exclude CO2 retention in these patients is prudent in the absence of blood gases. A similar strategy should be employed in patients with asthma,119 neuromuscular disease,117 and obesity hypoventilation syndrome.118 Oxygen provided by nasal cannula forms a reservoir in the nasopharynx that is entrained during inspiration.
- 1
Current address: The Mary Imogene Hospital, Cooperstown, New York.